Stay updated on Aurinia Pharmaceuticals Press Releases
Sign up to get notified when there's something new on the Aurinia Pharmaceuticals Press Releases page.

Latest updates to the Aurinia Pharmaceuticals Press Releases page
- Check2 days agoChange DetectedThe webpage has been updated with significant news regarding Aurinia Pharmaceuticals, including announcements of positive study results, financial reports, and shareholder recommendations. Notably, the addition of new data on LUPKYNIS® and updates on corporate progress are highlighted.SummaryDifference100%
- Check9 days agoChange DetectedThe webpage has undergone significant deletions, removing core content related to the company's mission, product information, and recent news updates, while only minor additions related to cookie consent and navigation have been made.SummaryDifference100%
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe page has added a significant new analysis regarding LUPKYNIS and its effects on lupus nephritis, while a previous announcement about a board appointment at Aurinia Pharmaceuticals has been removed.SummaryDifference10%
- Check45 days agoChange DetectedThe page has removed the 'Company Info' section and added a 'Corporate Presentation' section.SummaryDifference2%
- Check52 days agoChange DetectedThe webpage has updated its financial reporting date to May 12, 2025, while removing the previous report from November 7, 2024, which included details on strategic restructuring and operational results.SummaryDifference12%
- Check59 days agoChange DetectedAurinia Pharmaceuticals has updated its financial reporting schedule, replacing the upcoming release of third quarter results with a new announcement for the first quarter of 2025.SummaryDifference9%
Stay in the know with updates to Aurinia Pharmaceuticals Press Releases
Enter your email address, and we'll notify you when there's something new on the Aurinia Pharmaceuticals Press Releases page.